The Randox Acusera Maternal Screening control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down’s Syndrome and Spina Bifida. Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase a separate control. • Lyophilised for enhanced stability • 100% human serum providing a matrix similar to patient samples • Three levels of control accurately covering the clinical range • Suitable for double, triple and quad screens • Third party control for an independent, unbiased assessment of performance • Reconstituted stability of 7 days at +2-8oC
Analytes AFP β hCG Inhibin A PAPP-A Total hCG Unconjugated Estriol
Write a review
Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad 3 (All reviews published will be entered into the next drawing on May 31st 2013).